Publications

  1. Smith DC, Zhang J, Jayasuriya S, Berisha V, Starling A, Schwedt TJ, Chong CD. The impact of headache intensity on speech in participants with migraine and acute post-traumatic headache. Headache. 2024 Aug 28 [Epub ahead of print]
    View PubMed
  2. Wethe JV, Bogle J, Dodick DW, Howard MD, Gould AR, Butterfield RJ, Buras MR, Adler J, Talaber A, Soma D, Starling AJ. Baseline Normative and Test-Retest Reliability Data for Sideline Concussion Assessment Measures in Youth. Diagnostics (Basel). 2024 Aug 1; 14 (15) Epub 2024 Aug 01
    View PubMed
  3. Buse DC, Cady R, Starling AJ, Buzby M, Spinale C, Steinberg K, Lenaburg K, Kymes S. Headache/migraine-related stigma, quality of life, disability, and most bothersome symptom in adults with current versus previous high-frequency headache/migraine and medication overuse: results of the Migraine Report Card survey. BMC Neurol. 2024 Jul 4; 24 (1):232 Epub 2024 July 04
    View PubMed
  4. Anderson CC, Iser CR, Hirte IL, Boddu S, Girardo ME, VanderPluym JH, Starling AJ. Sequential administration of peripheral nerve blocks and onabotulinumtoxinA for the treatment of chronic migraine and other headache disorders-A retrospective tolerability and safety study. Headache. 2024 Jun; 64 (6):663-673 Epub 2024 May 03
    View PubMed
  5. Nikolova S, Chong C, Li J, Wu T, Dumkrieger G, Ross K, Starling A, Schwedt TJ. Brain structural and functional abnormalities associated with acute post-traumatic headache: iron deposition and functional connectivity. J Headache Pain. 2024 May 28; 25 (1):88
    View PubMed
  6. Chen YC, Wang H, Mandrekar JN, Robertson CE, Starling AJ, Cutrer FM, Chiang CC. Pharmacogenomic study-A pilot study of the effect of pharmacogenomic phenotypes on the adequate dosing of verapamil for migraine prevention. Pharmacogenomics J. 2024 Apr 9; 24 (3):11 Epub 2024 Apr 09
    View PubMed
  7. Starling AJ, Cady R, Buse DC, Buzby M, Spinale C, Steinberg K, Lenaburg K, Kymes S. Harris Poll Migraine Report Card: population-based examination of high-frequency headache/migraine and acute medication overuse. J Headache Pain. 2024 Feb 26; 25 (1):26
    View PubMed
  8. Arca KN, Lambru G, Starling AJ. Neuromodulation in migraine. Handb Clin Neurol. 2024; 199:179-200
    View PubMed
  9. Starling AJ, Cady R, Buse DC, Buzby M, Lenaburg K. A population-based survey of Americans with frequent migraine and acute medication use: A plain language summary. Pain Manag. 2024; 14 (7):335-345 Epub 2024 Sept 18
    View PubMed
  10. Ashina M, Tepper SJ, Gendolla A, Sperling B, Ettrup A, Josiassen MK, Starling AJ. Long-term effectiveness of eptinezumab in patients with migraine and prior preventive treatment failures: extension of a randomized controlled trial. J Headache Pain. 2023 Nov 20; 24 (1):155
    View PubMed
  11. Starling AJ, Kolbet M, Cady R, Brevig T. Treatment with eptinezumab for migraine prevention in people with chronic migraine and medication-overuse headache: a plain language summary. Pain Manag. 2023 Jun; 13 (6):317-327 Epub 2023 June 26
    View PubMed
  12. Starling AJ, Mallick-Searle T, Shrewsbury SB, Aurora SK. INP104: a drug evaluation of a nonoral product for the acute treatment of migraine. Pain Manag. 2023 May; 13 (5):283-298 Epub 2023 June 20
    View PubMed
  13. Vanood A, Rangel IC, Starling AJ. Migraine and the Gender Divide. Neurol Clin. 2023 May; 41 (2):231-247
    View PubMed
  14. Starling AJ, Kymes S, Asher D, Soni-Brahmbhatt S, Karnik-Henry M. Early clinical experience with eptinezumab: results of a retrospective observational study of patient response in the United States. BMC Neurol. 2023 Apr 20; 23 (1):158
    View PubMed
  15. Faubion SS, Ghaith S, Kling JM, Mara K, Enders F, Starling AJ, Kapoor E. Migraine and sleep quality: does the association change in midlife women? Menopause. 2023 Apr 1; 30 (4):376-382 Epub 2023 Jan 30
    View PubMed
  16. Kudrow D, Dafer R, Dodick DW, Starling A, Ailani J, Dougherty C, Kalidas K, Zhang F, Jeswani R, Patel N, Khodavirdi AC. Evaluation of vascular risk in patients with migraine with and without aura treated with erenumab: Post hoc analysis of pooled long-term clinical trial data. Headache. 2023 Mar; 63 (3):418-428
    View PubMed
  17. Starling AJ, Cowan RP, Buse DC, Diener HC, Marmura MJ, Hirman J, Brevig T, Cady R. Eptinezumab improved patient-reported outcomes in patients with migraine and medication-overuse headache: Subgroup analysis of the randomized PROMISE-2 trial. Headache. 2023 Feb; 63 (2):264-274 Epub 2023 Jan 12
    View PubMed
  18. Cowan RP, Marmura MJ, Diener HC, Starling AJ, Schim J, Hirman J, Brevig T, Cady R. Quantity changes in acute headache medication use among patients with chronic migraine treated with eptinezumab: subanalysis of the PROMISE-2 study. J Headache Pain. 2022 Sep 6; 23 (1):115 Epub 2022 Sept 06
    View PubMed
  19. Bogle JM, King AZ, Deep N, Weisskopf P, Starling AJ. Static Subjective Visual Vertical (SVV) in Patients with Vestibular Migraine. J Am Acad Audiol. 2022 Jul; 33 (7-08):396-404 Epub 2022 Sept 07
    View PubMed
  20. Starling AJ, Cortez MM, Jarvis NR, Zhang N, Porreca F, Chong CD, Schwedt TJ. Cutaneous heat and light-induced pain thresholds in post-traumatic headache attributed to mild traumatic brain injury. Headache. 2022 Jun; 62 (6):726-736 Epub 2022 June 07
    View PubMed
  21. Kuruvilla DE, Mann JI, Tepper SJ, Starling AJ, Panza G, Johnson MAL. Phase 3 randomized, double-blind, sham-controlled Trial of e-TNS for the Acute treatment of Migraine (TEAM). Sci Rep. 2022 Mar 24; 12 (1):5110
    View PubMed
  22. Marmura MJ, Diener HC, Cowan RP, Tepper SJ, Diamond ML, Starling AJ, Hirman J, Mehta L, Brevig T, Cady R. Preventive migraine treatment with eptinezumab reduced acute headache medication and headache frequency to below diagnostic thresholds in patients with chronic migraine and medication-overuse headache. Headache. 2021 Oct; 61 (9):1421-1431 Epub 2021 Sept 22
    View PubMed
  23. Begasse de Dhaem O, Kiarashi J, Armand CE, Charleston L 4th, Szperka CL, Lee YS, Rajapakse T, Seng EK, VanderPluym JH, Starling AJ. Ten Eleven things to facilitate participation of underrepresented groups in headache medicine research. Headache. 2021 Jun; 61 (6):951-960 Epub 2021 June 14
    View PubMed
  24. Chiang CC, Arca KN, Dunn RB, Girardo ME, Quillen JK, Dodick DW, Starling AJ. Real-world efficacy, tolerability, and safety of ubrogepant. Headache. 2021 Apr; 61 (4):620-627 Epub 2021 Feb 05
    View PubMed
  25. Caronna E, Starling AJ. Update on Calcitonin Gene-Related Peptide Antagonism in the Treatment of Migraine. Neurol Clin. 2021 Feb; 39 (1):1-19 Epub 2020 Nov 07
    View PubMed
  26. Ailani J, Rabany L, Tamir S, Ironi A, Starling A. Real-World Analysis of Remote Electrical Neuromodulation (REN) for the Acute Treatment of Migraine. Front Pain Res (Lausanne). 2021; 2:753736 Epub 2022 Jan 18
    View PubMed
  27. Diener HC, Marmura MJ, Tepper SJ, Cowan R, Starling AJ, Diamond ML, Hirman J, Mehta L, Brevig T, Sperling B, Cady R. Efficacy, tolerability, and safety of eptinezumab in patients with a dual diagnosis of chronic migraine and medication-overuse headache: Subgroup analysis of PROMISE-2. Headache. 2021 Jan; 61 (1):125-136 Epub 2020 Dec 13
    View PubMed
  28. Blech B, Starling AJ. Noninvasive Neuromodulation in Migraine. Curr Pain Headache Rep. 2020 Dec 16; 24 (12):78
    View PubMed
  29. Robblee J, Starling AJ. E-Consultation in Headache Medicine: A Quality Improvement Pilot Study. Headache. 2020 Nov; 60 (10):2192-2201 Epub 2020 Oct 16
    View PubMed
  30. Ford JH, Kurth T, Starling AJ, Ayer DW, Wietecha LA, Port MD, Rettiganti M, Ruff DD. Migraine Headache Day Response Rates and the Implications to Patient Functioning: An Evaluation of 3 Randomized Phase 3 Clinical Trials of Galcanezumab in Patients With Migraine. Headache. 2020 Nov; 60 (10):2304-2319
    View PubMed
  31. Robblee J, Devick KL, Mendez N, Potter J, Slonaker J, Starling AJ. Real-World Patient Experience With Erenumab for the Preventive Treatment of Migraine. Headache. 2020 Oct; 60 (9):2014-2025 Epub 2020 Sept 13
    View PubMed
  32. Arca KN, Starling AJ. Advocacy in Headache Medicine: Tips at the Bedside, the Institutional Level, and Beyond. Curr Neurol Neurosci Rep. 2020 Sep 17; 20 (11):52 Epub 2020 Sept 17
    View PubMed
  33. Arca KN, Smith JH, Chiang CC, Starling AJ, Robertson CE, Halker Singh RB, Schwedt TJ, Kissoon NR, Garza I, Rozen TD, Boes CJ, Whealy MA, VanderPluym JH. COVID-19 and Headache Medicine: A Narrative Review of Non-Steroidal Anti-Inflammatory Drug (NSAID) and Corticosteroid Use. Headache. 2020 Sep; 60 (8):1558-1568 Epub 2020 July 10
    View PubMed
  34. Blech B, Starling AJ, Marks LA, Wingerchuk DM, O'Carroll CB. Is Noninvasive Vagus Nerve Stimulation a Safe and Effective Alternative to Medication for Acute Migraine Control? Neurologist. 2020 Jul; 25 (4):97-100
    View PubMed
  35. Chiang CC, VanderPluym JH, Starling AJ. Teaching Images in Headache: Is This Just a Post-Dural Puncture Headache? A Case Report. Headache. 2020 Jun; 60 (6):1202-1203 Epub 2020 May 18
    View PubMed
  36. Arca K, Starling AJ. Idiopathic Intracranial Hypertension. Practicalneurology.com. 2020.
  37. VanderPluym JH, Mead-Harvey C, Starling AJ. Pressing Issues Among Trainees and Early Career Physicians in Headache Medicine: Survey Results From the American Headache Society New Investigator and Trainee Section and International Headache Academy. Headache. 2020 Apr; 60 (4):745-751 Epub 2020 Feb 07
    View PubMed
  38. Chiang CC, VanderPluym J, Starling AJ. Is this just a post-lumbar puncture (LP) headache? Headache (Accepted). 2020.
  39. Arca KN, Starling AJ, Acierno MD, Demaerschalk BM, Marks L, O'Carroll CB. Is King-Devick Testing, Compared With Other Sideline Screening Tests, Superior for the Assessment of Sports-related Concussion?: A Critically Appraised Topic. Neurologist. 2020 Mar; 25 (2):33-37
    View PubMed
  40. Chiang CC, Starling AJ, Buras MR, Golafshar MA, VanderPluym JH. A pilot exploratory study comparing the King-Devick test (KDT) during and between migraine attacks. Cephalalgia. 2020 Mar; 40 (3):307-312 Epub 2019 Oct 29
    View PubMed
  41. Arca KN, Starling AJ. Treatment-Refractory Headache in the Setting of COVID-19 Pneumonia: Migraine or Meningoencephalitis? Case Report. SN Compr Clin Med. 2020; 2 (8):1200-1203 Epub 2020 June 25
    View PubMed
  42. Borrero-Mejias C, Starling AJ, Burch R, Loder E, Migraine Mavens Writing Consortium, Migraine Mavens Writing Consortium . Eleven Things Not to Say to Your Female Colleagues. Headache. 2019 Nov; 59 (10):1846-1854 Epub 2019 Sept 26
    View PubMed
  43. Robblee J, Starling AJ. SEEDS for success: Lifestyle management in migraine. Cleve Clin J Med. 2019 Nov; 86 (11):741-749
    View PubMed
  44. VanderPluym JH, Hamilton K, Hindiyeh NA, Robbins MS, Starling AJ, Vargas BB, Gibbons SK, Vgontzas A. Online Migraine Education and Support for Patients: Perspectives from the American Headache Society Emerging Leaders Program. Headache. 2019 Oct; 59 (9):1656-1658 Epub 2019 Sept 11
    View PubMed
  45. Shapiro RE, Hochstetler HM, Dennehy EB, Khanna R, Doty EG, Berg PH, Starling AJ. Lasmiditan for acute treatment of migraine in patients with cardiovascular risk factors: post-hoc analysis of pooled results from 2 randomized, double-blind, placebo-controlled, phase 3 trials. J Headache Pain. 2019 Aug 29; 20 (1):90
    View PubMed
  46. Robblee JV, Mendez N, Potter J, Slonaker J, Grimsrud KW, Starling AJ. Post-market observational study of patient experience with erenumab. Headache. 2019 Jun; 59(Suppl 1):48-9. Epub 1900 Jan 01.
  47. Jackson WT, Starling AJ. Concussion Evaluation and Management. Med Clin North Am. 2019 Mar; 103 (2):251-261 Epub 2018 Dec 03
    View PubMed
  48. Starling AJ. Unusual Headache Disorders. Continuum (Minneap Minn). 2018 Aug; 24 (4, Headache):1192-1208
    View PubMed
  49. Schroeder RA, Brandes J, Buse DC, Calhoun A, Eikermann-Haerter K, Golden K, Halker R, Kempner J, Maleki N, Moriarty M, Pavlovic J, Shapiro RE, Starling A, Young WB, Nebel RA. Sex and Gender Differences in Migraine-Evaluating Knowledge Gaps. J Womens Health (Larchmt). 2018 Aug; 27 (8):965-973
    View PubMed
  50. Starling A. Noninvasive neuromodulation in migraine and cluster headache. Curr Opin Neurol. 2018 Jun; 31 (3):268-273
    View PubMed
  51. Starling AJ, Tepper SJ, Marmura MJ, Shamim EA, Robbins MS, Hindiyeh N, Charles AC, Goadsby PJ, Lipton RB, Silberstein SD, Gelfand AA, Chiacchierini RP, Dodick DW. A multicenter, prospective, single arm, open label, observational study of sTMS for migraine prevention (ESPOUSE Study). Cephalalgia. 2018 May; 38 (6):1038-1048 Epub 2018 Mar 04
    View PubMed
  52. Depre C, Antalik L, Starling A, Koren M, Eisele O, Lenz RA, Mikol DD. A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Erenumab on Exercise Time During a Treadmill Test in Patients With Stable Angina. Headache. 2018 May; 58 (5):715-723
    View PubMed
  53. Allen SM, Mookadam F, Cha SS, Freeman JA, Starling AJ, Mookadam M. Greater Occipital Nerve Block for Acute Treatment of Migraine Headache: A Large Retrospective Cohort Study. J Am Board Fam Med. 2018 Mar-Apr; 31 (2):211-218
    View PubMed
  54. Starling AJ. Diagnosis and Management of Headache in Older Adults. Mayo Clin Proc. 2018 Feb; 93 (2):252-262
    View PubMed
  55. Chiang CC, Starling AJ. OnabotulinumtoxinA in the treatment of patients with chronic migraine: clinical evidence and experience. Ther Adv Neurol Disord. 2017 Dec; 10 (12):397-406 Epub 2017 Sept 20
    View PubMed
  56. Dhawan PS, Leong D, Tapsell L, Starling AJ, Galetta SL, Balcer LJ, Overall TL, Adler JS, Halker-Singh RB, Vargas BB, Dodick D. King-Devick Test identifies real-time concussion and asymptomatic concussion in youth athletes. Neurol Clin Pract. 2017 Dec; 7 (6):464-473
    View PubMed
  57. Steenerson K, Starling AJ. Pathophysiology of Sports-Related Concussion. Neurol Clin. 2017 Aug; 35 (3):403-408 Epub 2017 May 30
    View PubMed
  58. Vargas BB, Shepard M, Hentz JG, Kutyreff C, Hershey LG, Starling AJ. Feasibility and accuracy of teleconcussion for acute evaluation of suspected concussion. Neurology. 2017 Apr 18; 88: (16)1580-1583.
    View PubMed
  59. Dodick D, Starling AJ, Wethe J, Pang Y, Messner LV, Smith C, Master CL, Halker-Singh RB, Vargas BB, Bogle JM, Mandrekar J, Talaber A, Leong D. The Effect of In-School Saccadic Training on Reading Fluency and Comprehension in First and Second Grade Students. J Child Neurol. 2017 Jan; 32 (1):104-111 Epub 2016 Oct 10
    View PubMed
  60. VanderPluym J, Evans RW, Starling AJ. Long-Term Use and Safety of Migraine Preventive Medications. Headache. 2016 Sep; 56 (8):1335-43 Epub 2016 Aug 01
    View PubMed
  61. Robbins MS, Starling AJ, Pringsheim TM, Becker WJ, Schwedt TJ. Treatment of Cluster Headache: The American Headache Society Evidence-Based Guidelines. Headache. 2016 Jul; 56 (7):1093-106
    View PubMed
  62. Chong CD, Starling AJ, Schwedt TJ. Interictal photosensitivity associates with altered brain structure in patients with episodic migraine. Cephalalgia. 2016 May; 36 (6):526-33 Epub 2015 Sept 16
    View PubMed
  63. Halker RB, Starling AJ, Vargas BB, Schwedt TJ. ACE and ARB Agents in the Prophylactic Therapy of Migraine-How Effective Are They? Curr Treat Options Neurol. 2016 Apr; 18 (4):15
    View PubMed
  64. Lipton RB, Serrano D, Buse DC, Pavlovic JM, Blumenfeld AM, Dodick DW, Aurora SK, Becker WJ, Diener HC, Wang SJ, Vincent MB, Hindiyeh NA, Starling AJ, Gillard PJ, Varon SF, Reed ML. Improving the detection of chronic migraine: Development and validation of Identify Chronic Migraine (ID-CM). Cephalalgia. 2016 Mar; 36 (3):203-15 Epub 2015 May 22
    View PubMed
  65. Starling AJ, Leong DF, Bogle JM, Vargas BB. Variability of the modified Balance Error Scoring System at baseline using objective and subjective balance measures. Concussion. 2016 Mar; 1 (1):CNC5 Epub 2015 Aug 06
    View PubMed
  66. Shepard MA, Silva A, Starling AJ, Hoerth MT, Locke DE, Ziemba K, Chong CD, Schwedt TJ. Patients with psychogenic nonepileptic seizures report more severe migraine than patients with epilepsy. Seizure. 2016 Jan; 34:78-82.
    View PubMed
  67. Starling AJ, Vargas BB. A Narrative Review of Evidence-Based Preventive Options for Chronic Migraine. Curr Pain Headache Rep. 2015 Oct; 19 (10):49
    View PubMed
  68. Minen MT, Monteith T, Strauss LD, Starling A. New Investigator and Trainee Task Force Survey on the Recruitment and Retention of Headache Specialists. Headache. 2015 Sep; 55 (8):1092-101 Epub 2015 Aug 03
    View PubMed
  69. Starling AJ, Dodick DW. Best practices for patients with chronic migraine: burden, diagnosis, and management in primary care. Mayo Clin Proc. 2015 Mar; 90 (3):408-14
    View PubMed
  70. Zaleski A, Bogle J, Starling A, Zapala DA, Davis L, Wester M, Cevette M. Vestibular evoked myogenic potentials in patients with vestibular migraine. Otol Neurotol. 2015 Feb; 36 (2):295-302
    View PubMed
  71. Leong DF, Master CL, Messner LV, Pang Y, Smith C, Starling AJ. The effect of saccadic training on early reading fluency. Clin Pediatr (Phila). 2014 Aug; 53: (9)858-64.
    View PubMed
  72. David PS, Kling JM, Starling AJ. Migraine in pregnancy and lactation. Curr Neurol Neurosci Rep. 2014 Apr; 14 (4):439
    View PubMed
  73. Starling A, Hernandez F, Hoxworth JM, Trentman T, Halker R, Vargas BB, Hastriter E, Dodick D. Sensitivity of MRI of the spine compared with CT myelography in orthostatic headache with CSF leak. Neurology. 2013 Nov 12; 81(20):1789-92. Epub 2013 Oct 09.
    View PubMed
  74. Starling AJ, Hoffman-Snyder C, Halker RB, Wellik KE, Vargas BB, Dodick DW, Demaerschalk BM, Wingerchuk DM. Risk of development of medication overuse headache with nonsteroidal anti-inflammatory drug therapy for migraine: a critically appraised topic. Neurologist. 2011 Sep; 17(5):297-9.
    View PubMed
  75. Starling AJ, Wellik KE, Hoffman Snyder CR, Aguilar MI, Demaerschalk BM, Zimmerman RS, Wingerchuk DM. Surgical decompression improves mortality and morbidity after large territory acute cerebral infarction: a critically appraised topic. Neurologist. 2011 Jan; 17(1):63-6.
    View PubMed
  76. Starling AJ, Andre VM, Cepeda C, de Lima M, Chandler SH, Levine MS. Alterations in N-methyl-D-aspartate receptor sensitivity and magnesium blockade occur early in development in the R6/2 mouse model of Huntington's disease. J Neurosci Res.2005 Nov 1;82:(3):377-86.
    View PubMed
  77. Cepeda C, Starling AJ, Wu N, Nguyen OK, Uzgil B, Soda T, Andre VM, Ariano MA, Levine MS. Increased GABAergic function in mouse models of Huntington's disease: reversal by BDNF. J Neurosci Res.2004 Dec 15;78:(6):855-67.
    View PubMed
  78. Andre VM, Flores-Hernandez J, Cepeda C, Starling AJ, Nguyen S, Lobo MK, Vinters HV, Levine MS, Mathern GW. NMDA receptor alterations in neurons from pediatric cortical dysplasia tissue. Cereb Cortex.2004 Jun;14:(6):634-46.
    View PubMed
  79. Hernandez-Echeagaray E, Starling AJ, Cepeda C, Levine MS. Modulation of AMPA currents by D2 dopamine receptors in striatal medium-sized spiny neurons: are dendrites necessary? Eur J Neurosci PubMed PMID 15128399.2004 May;19:(9):2455-63.